라이프
전체기사 보기-
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants
- The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026- Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndromic PCR assays, instruments, and software- Program aims to advance Seegene's Technology-Sharing Initiative and expand access to molecular diagnostics SEOUL, South Korea, Sept. 2, 2025 -- Seegene Inc., a global leader in molecular diagnostics, announced today the launch of the 20
- 김갑성 기자
- 2025-09-02 21:00
-
Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer's disease and Dementia Data
Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related data Enhancing dementia research by integrating AI imaging solutions with real-world data platforms SEOUL, South Korea, Sept. 2, 2025 -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a Memorandum of Understanding (MoU) with the International Registry for Alzheimer's Disease and Other Dementias Foundation (I
- 김갑성 기자
- 2025-09-02 21:00
-
Desilo to Launch "HARVEST™," Encrypted Data Collaboration Platform for Healthcare, in December
SEOUL, South Korea, Sept. 2, 2025 -- Desilo Inc., a privacy-technology startup specializing in cryptographic data collaboration, announced plans to launch its new healthcare platform, HARVEST™, this December. The platform is designed to allow medical institutions and pharmaceutical companies to collaborate on research without exposing sensitive patient data. Medical research often requires large, multi-institutional datasets, but privacy regulations and security risks have made data sharing difficult. According to IBM, the average cost of a healthcare data breach is $10.93 mill
- 김갑성 기자
- 2025-09-02 21:00
-
Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program
Milestone European deployment underscores growing global trust in Lunit's AI for population-wide breast cancer screening SEOUL, South Korea, Sept. 2, 2025 -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that its solutions have been selected as the exclusive AI tools for the breast cancer screening program of the Valencian Community, one of Spain's largest and most progressive healthcare regions. With a population of approximately 5 million, the Valencian Community is Spain's third-largest region by popul
- 김갑성 기자
- 2025-09-02 21:00
-
BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform
XI'AN, China, Sept. 2, 2025 -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds from a tea-derived product via its AI-Powered new drug research and development (R&D) platform. Preliminary tests demonstrate that these compounds exhibit significant activity in weight management, with key efficacy indicators outperforming current mainstream weight-managing drugs, injecting
- 황정호 기자
- 2025-09-02 20:30
-
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen, Denmark: EFFICIENT, CONFIDENT DECISION MAKING: introducing AI-powered CIRRUS® PathFinder™ clinical support tool now CE mark approved; presenting a fully integrated diagnostic and SLT therapeutic solution for managing comorbid cataract/glaucoma patients. NEW STANDARDS IN SURGICAL EXCELLENCE: showcasing the DORC EVA NEXUS™ dual strategy surgical platform as part of ZEISS's expanding surgical workflow solutions. IMPROVED PREDICTABILITY OUTCOM
- 김갑성 기자
- 2025-09-02 20:00
-
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift
Approximately 800 children aged 12 months to 12 years in Korea and abroad, aiming for completion by 2027 Rising demand for 2-dose regimen as international standards amid projected global market growth to USD 6.3 billion by 3034 SKBS continues strategic R&D to enhance global vaccine competitiveness of its vaccine pipelines SEONGNAM, South Korea, Sept. 2, 2025 -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has submitted an IND (Investigational New Drug application)
- 김갑성 기자
- 2025-09-02 19:00
-
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
[ 메디채널 김갑성 기자 ] - Ascletis to present data from the U.S. Phase Ib clinical study of ASC30 oral tablet in oral discussion - On track to report topline data from Phase IIa clinical study of ASC30 oral tablet in participants with obesity or overweight in the fourth quarter of 2025 HONG KONG, Sept. 2, 2025 -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that data from its 28-day multiple ascending dose study of its oral small molecule GLP-1 receptor (GLP-1R) agonist ASC30 (NCT06680440) will be presented in a short oral discussion at the 61st European Associ
- 김갑성 기자
- 2025-09-02 18:00
-
Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights
SHANGHAI, Sept. 2, 2025 -- Peptides have recently emerged at the forefront of therapeutic innovation, with cyclic peptides gaining particular attention for their ability to bridge the gap between small molecules and large biologics. Positioned between the two, cyclic peptides combine the oral potential of small molecules with the structural advantages of biologics—making them ideally suited to address traditionally "undruggable" protein–protein interactions and complex receptors, while opening new avenues for oral drug discovery. With global investment in peptide pipelines steadily
- 김갑성 기자
- 2025-09-02 17:52
-
Nuffield Holdings Welcomes Strategic Shareholders to Drive Next Phase of Regional Growth
[ 메디채널 김갑성 기자 ] Capital injection to accelerate M&A, AI-led operations, and expansion across Southeast Asia and the Middle East. SINGAPORE, Sept. 2, 2025 -- Nuffield Holdings is pleased to announce the appointment of Mr Liu Song and Ms Zhang Na as new shareholders, marking a pivotal moment in the Group's regional growth strategy. This investment brings in both capital and strategic insight, enabling Nuffield to accelerate mergers and acquisitions, scale operations, and enhance its leadership in Southeast Asia's healthcare sector. Experienced and Visionary Partners M
- 김갑성 기자
- 2025-09-02 16:45
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-09-03_WED
- Scan, Play, Discover: Orca Scan Launches QR-Powered Retro Game 05:00
- Midea to become new FC Barcelona Main Partner 01:38
2025-09-02_TUE
- US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively 21:10
- NYSE Content Advisory: Pre-Market update + S&P 500 ends August up nearly 2% 21:01
- Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants 21:00
- Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer's disease and Dementia Data 21:00
- Desilo to Launch "HARVEST™," Encrypted Data Collaboration Platform for Healthcare, in December 21:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 09월 03일 06시 40분